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Welcome to Clinical Ophthalmology
Welcome to Clinical Ophthalmology, a new general ophthalmology journal from 
Dove Medical Press.
The aim of the journal is to produce high quality research for and from eyecare 
practitioners all over the world. To do this we are determined to use all the good things 
about traditional medical publishing combined with the most up-to-date electronic 
means of presenting them. Academic publishing has undergone a revolution over the 
last 10 years but the same basic principles hold—well-written, informative articles 
that have been reviewed by at least one peer—are the core of any journal. You can 
see if we live up to these principles by following Clinical Ophthalmology over the 
forthcoming months and years.
The title, Clinical Ophthalmology, is deliberate and indicates that we publish papers 
that have a relevance to the practitioner in the eye clinic. This does not mean that we 
avoid papers related to basic science research—on the contrary, we hope to publish 
widely in translational research. Similarly, any type of practitioner who is involved 
in the care of ophthalmic patients is welcome as both reader and author. The days 
when medical journals were solely for medically qualiﬁ  ed readers are disappearing 
as rapidly as journals that do not have a web presence.
This spectrum of research from bedside to the benchside is well illustrated in this 
ﬁ  rst edition. On the clinical side, Schoser and colleagues discuss the clinical features 
and management of ocular myositis—a condition easily missed in its early stages. 
We report a clinical trial from Mahfouz looking at that most pragmatic of topics—the 
best anesthetic to use during cataract extraction. On the laboratory side, Langford and 
colleagues discuss the role of glutamine in the ciliary body whilst Yalcindag and team 
report on the penetration of tarcolimus into the anterior chamber. Research bridging 
the gap between the laboratory and the clinic is described by Friedlaender in the 
description of the development of an ocular anti-infective. 
Finally, any medical journal is a work in progress. Readers and authors’ tastes 
and opinions change, and a good journal should follow these changes. If you have 
any idea for articles (especially if you want to write them yourself), changes in the 
journal or even just to say which bits you like (or dislike) please email me directly at 
the address below. Like the web, without reader input a journal will wither and die. So 
please do get involved and remember there are rarely any ‘right’ or ‘wrong’ answers 
in medicine, but simply different experiences and opinions.
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